… with a focus on pharmacological therapies for obesity approved over the last decade …
new obesity pharmacotherapies. We also discuss the future directions of obesity pharmacotherapy …

… therapies to help tackle the growing obesity epidemic and the healthcare crisis it poses. The
past 3 years have seen approval of a number of novel anti-obesity … combination therapies, …

… of safe and effective therapies that provide a substantial benefit for the obese, with the … for
the development of new therapeutic interventions for the treatment of obesity. OBESITY AS A …

… These new therapies act primarily at molecular targets in the CNS to decrease appetite.
Most FDA-approved weight loss drugs are orally active, with the exception of liraglutide, which …

… Keith’s article, “Pharmacotherapy in Treatment of Obesity,” in this issue), but this article
discusses possible new therapies that may be used as a supplement to diet therapy and exercise…

… Therapies specifically targeted to … new understanding of the regulation of body-energy
homeostasis, we can anticipate that in the future we will probably be able to treat obesity with new …

… obesity relapse. Currently, only five drug therapies are approved for the specific treatment of
obesity… However, our understanding of the pathophysiology of obesity and of gut hormones …

… gut hormone-based pharmacotherapies for obesity and type 2 diabetes … obesity-related
complications. Tirzepatide, a dual agonist of GLP1 and GIP receptors, marks a new era in obesity …

… management of obesity. In this review, we first describe the clinical features of obesity-…
therapies for obesity as well as new ones expecting to reach the clinic in the near future. …

… the global obesity epidemic and its comorbidities. Current pharmacologic options for obesity
… Therefore, the need for safe and more efficacious new agents is urgent. Drugs that are …